wire - news in brief
Category
Results 201 - 250 of 436.
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri
At NEST, the research and innovation platform of Empa and Eawag, a new unit is currently being planned: STEP2.
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif * in chronic myeloid leukemia trial
At 24 weeks, asciminib nearly doubled the major molecular response (MMR) rate compared to Bosulif (bosutinib)*, in patients resistant to, or intolerant of, at least two prior tyrosine kinase inhibito
At 24 weeks, asciminib nearly doubled the major molecular response (MMR) rate compared to Bosulif (bosutinib)*, in patients resistant to, or intolerant of, at least two prior tyrosine kinase inhibito
COVID-19: persistent symptoms in one third of cases
Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.
Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
Latest data to be presented at ASH 2020 includes results in non-Hodgkin lymphoma and heavily pre-treated multiple myeloma Portfolio includes two CD20xCD3 bispecifics, mosunetuzumab and glofitamab, an
Latest data to be presented at ASH 2020 includes results in non-Hodgkin lymphoma and heavily pre-treated multiple myeloma Portfolio includes two CD20xCD3 bispecifics, mosunetuzumab and glofitamab, an
Novartis analyses confirm benefit of Kymriah with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a complete response and the overall response rate was 83% 1 L
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a complete response and the overall response rate was 83% 1 L
Novartis announces first data from REACH3 trial showing Jakavi (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD
Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 Chronic graft-versus-host disease (GvHD) is a life-threatening complic
Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 Chronic graft-versus-host disease (GvHD) is a life-threatening complic
Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems.
ETH Zurich supports art in construction, and, as part of a project competition, has selected art projects by Maya Rochat and Yves Netzhammer that take an innovative approach to reflecting on teaching and research in the two ETH buildings BSS and ML-FHK.
Natural Selection also Increases the Adaptability of Organism
Natural selection causes organisms to adapt continuously. Researchers at the University of Zurich now show for the first time that proteins in bacteria develop a new property more rapidly when the selection pressure is high. Natural selection can thus also increase the evolutionary capacity itself.
Natural selection causes organisms to adapt continuously. Researchers at the University of Zurich now show for the first time that proteins in bacteria develop a new property more rapidly when the selection pressure is high. Natural selection can thus also increase the evolutionary capacity itself.
Engineers from the ETH Feasibility Lab are working together with the ICRC to develop a prosthetic leg that allows easy replacement of its wearing part.
If innovative projects and achievements in technology transfer stand out, they should be honored accordingly.
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein is the target of many COVID-19 vaccines in development This test may help identif
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein is the target of many COVID-19 vaccines in development This test may help identif
Roberto Gargiani, an architectural historian and professor at EPFL, has penned a new history of concrete in the United States from 1940 to 1970.
The analysis of DNA fragments and their assignment to individual species - an increasingly well-established approach - is transforming biodiversity assessment. Samples collected from waterbodies permit rapid biomonitoring of aquatic ecosystems. However, environmental DNA (eDNA) analysis is not without pitfalls.
During the lockdown last spring, Julian Ferchow put his doctoral project aside to help relieve the strain on hospitals.
Bread wheat can grow in highly diverse regional environments. An important reason for its great genetic variety is the cross-hybridization with many chromosome fragments from wild grasses. This is shown by the genome sequences of 10 wheat varieties from four continents, which an international consortium including researchers from the University of Zurich has now decoded.
ETH Zurich intends to further expand its leading position in quantum research, and so it is planning a highly specialised physics laboratory building on the Hönggerberg campus.
Iron-deficiency anaemia is a major concern in low income countries, especially for women. A study conducted in Tanzania has now demonstrated the advantage of iron infusion therapy over the usual treatment with iron tablets.
Tackling pandemic threats proactively
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.
The gravity of dreams
Why is gravity the most mysterious force of nature? Lavinia Heisenberg studies how the universe was formed, and how it is changing.
Why is gravity the most mysterious force of nature? Lavinia Heisenberg studies how the universe was formed, and how it is changing.
At Eawag, the aquatic research institute, numerous scientists are conducting research into toilets. In short videos, seven of them explain what fascinates them about the topic and what exactly their research is all about.
A new exhibition in the Ethnographic Museum of the University of Zurich delves into the recent history of the Ayoréode, a nomadic people in the forests of Bolivia, who have had to adapt to settled life for decades.
